Floating Button
Home Capital Healthcare

IHH looks beyond Covid; analysts see turnaround in 2HFY2020

Goola Warden
Goola Warden • 5 min read
IHH looks beyond Covid; analysts see turnaround in 2HFY2020
The year 2020 has indeed been challenging for IHH’s Singapore operations because of Covid-19 and the practical closure of its borders, limiting inbound and medical tourists alike.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Since the start of the year, IHH Healthcare’s share price has fallen some 6% while ParkwayLife REIT (PLife REIT), in which IHH has a 35.7% stake, is up almost 8% this year.

Unlike PLife REIT, which has downside protection for its rental income, IHH is subject to the vagaries of the market. IHH has sizeable operations in Turkey through Acibadem, a growing presence in China, and in India where it owns 31% of Fortis Healthcare. IHH planned to acquire an additional 26% in Fortis but that deal is now bogged down in litigation.

In the past 13 years, the three hospitals and Mount Elizabeth Novena in Singapore have benefitted from a growth in medical tourism-related healthcare, and also healthcare in general. After all, the city state, with its ageing population is reportedly home to 207,000 millionaires, based on a Credit Suisse survey.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.